Benjamin Paluch

Stock Analyst

(n/a)
# 4,648
Out of 4,648 analysts
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Benjamin Paluch

CG Oncology
Aug 27, 2024
Initiates: Buy
Price Target: $65
Current: $36.78
Upside: +76.73%
Replimune Group
Aug 27, 2024
Initiates: Buy
Price Target: $17
Current: $12.02
Upside: +41.43%
Genelux
Aug 27, 2024
Initiates: Buy
Price Target: $10
Current: $3.07
Upside: +225.73%